File(s) not publicly available
AMPA receptor positive allosteric modulators – a case history
chapter
posted on 2023-06-08, 20:16 authored by Simon WardSignificant advances have been made over recent years in our understanding of the tremendous complexity underlying the function of the human brain, in particular gaining insight into the mechanisms of synaptic plasticity which are key to developmental, adaptive and learning processes. Glutamate, the major excitatory neurotransmitter in the central nervous system (CNS), is of critical importance to these processes, acting at chemical synapses on two major classes of receptors – the metabotropic family of G-protein coupled receptors (mGluRs 1-8), and ionotropic family of ion channel forming receptors (iGluRs). The latter comprises the a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid (AMPA), N-methyl-d-aspartate (NMDA) and kainate receptors. Despite similarities shared within this ion channel family, there exist clear structural and pharmacological differences which underlie their individual modes of action. This chapter provides a case history of ion channel lead optimisation, discusses challenges in lead optimisation and selection of clinical discovery candidates, and thoughts on the future of drug discovery programmes.
History
Publication status
- Published
Publisher
Royal Society of ChemistryExternal DOI
Page range
105-134Book title
Ion channel drug discoveryISBN
9781849731867Series
RSC drug discoveryDepartment affiliated with
- Chemistry Publications
Full text available
- No
Peer reviewed?
- Yes
Editors
Brian Cox, Martin GoslingLegacy Posted Date
2015-03-09Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC